Arazlo Lotion
Product Images NDC 0187-2098

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Arazlo (NDC 0187-2098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

ARAZLO is a topical lotion for dermatological use only. It contains 0.45 mg (0.045%) of tazarotene in a lotion base consisting of several ingredients. The recommended dosage should be consulted in the prescribing information. Keep out of reach of children and do not apply orally, ophthalmic, or intravaginally. Store between 20°C to 25°C (68°F to 77°F) with permitted excursions of up to 15°C to 30°C (59°F to 86°F). The product is manufactured by Bausch Health Companies Inc. in Canada and distributed by ARAZLO and Ortho Dermatologics, which are trademarks of Bausch Health US, LLC.*

FDA Label Image

Chemstructure (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.